Literature DB >> 9206712

[Dapsone in granulomatous rosacea].

M H Krause1, R Torricelli, T Kündig, R M Trüeb, J Hafner.   

Abstract

We report on two patients with granulomatous rosacea and another patient with granulomatous perioral dermatitis who responded well to dapsone. Dapsone has a pharmacological double function as both an antibiotic and an antiphlogistic drug. Before the introduction of isotretinoin, dapsone had its place in the treatment of severe acne. To date, its use in granulomatous rosacea has not been described. When hematologic parameters are monitored, dapsone is considered a safe and cost-effective drug, especially in countries where isotretinoin is not readily available. However, the definite value of dapsone in granulomatous rosacea should be established by a controlled study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9206712     DOI: 10.1007/s001050050577

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  4 in total

Review 1.  [Facial manifestations of granulomatous diseases].

Authors:  F Butsch
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

Review 2.  [Rosacea. Clinical features, pathogenesis and therapy].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

3.  [Systemic therapy of rosacea].

Authors:  M Schaller; K Belge
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

4.  [Successful treatment of granulomatous rosacea with dapsone].

Authors:  L M Ehmann; S Meller; B Homey
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.